Virtual Medicinal Product (VMP)
-
Testosterone 30mg modified-release muco-adhesive buccal tablets
Name Details
Current Name
Testosterone 30mg modified-release muco-adhesive buccal tablets
|
Start Date
02-06-2004
|
End Date
|
|
Abbreviated Name
Testosterone 30mg modified-release muco-adhesive buccal tab
|
Start Date
01-05-2009
|
|
Testosterone 30mg MR muco-adhesive buccal tablets |
Previous Start Date
14-09-2004
|
Previous End Date
30-04-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Anab)
- Route
- Buccal
- Form
- Muco-adhesive buccal tablet
- Ontology Form/Route
- tabletbuccalmodified-releasemuco-adhesive.buccal
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03BA03
BNF |
Current BNF
06040200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06040200
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
7503511000001104 |
02-06-2004 |
|
VMP Ingredients
VMP ingredients table
Testosterone |
Based on Ingredient Substance |
|
30 mg |
|
Name
Testosterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
30.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Testosterone
-
VMP
(Current) Testosterone 30mg modified-release m...
Virtual Medicinal Product Pack (VMPP) Information